Viruses readily evolve, and SARS-CoV-2 is no exception. With the advent of several SARS-CoV-2 vaccines, scientists are concerned about the possibility of escape variants as new variants continue to emerge. These variants evade critical antibody residues required for binding and immune detection and may affect vaccine efficacy. In this webinar, scientists will discuss the emergence of SARS-CoV-2 variants and strategies for monitoring, tracking, and mitigating SARS-CoV-2 escape variants.
Topics to be covered
Speaker Information:
Dirk P. Dittmer, PhD
Professor, Department of Microbiology and Immunology
Lineberger Comprehensive Cancer Center
Program Leader Global Oncology
Program Leader Virology
Director, UNC Vironomics Core
University of North Carolina at Chapel Hill
Zhiqiang Ku, PhD
Postdoctoral Fellow
Laboratory of Zhiqiang An, PhD
Texas Therapeutic Institute
University of Texas Health Science Center at Houston
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2025 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy